Medpage Today on MSN3d
Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free SurvivalAdding a PD-1 inhibitor to standard of care improved disease-free survival (DFS) in stage III soft-tissue sarcoma of the ...
Pembrolizumab, an immunotherapy medication, significantly enhanced disease-free survival when added to the standard of care ...
The EFTISARC-NEO trial, with a data cut-off of 20 October 2024, also showed 71.4% of patients achieved a pathologic response ...
Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...
Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free survival, according to the results ...
PITTSBURGH — Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue ...
James McMahon – Kerrang! Editor from 2011 to 2017 – has died from soft tissue sarcoma.
Immutep (IMMP) has released an update. Immutep Limited has announced promising results from its Phase II trial of eftilagimod alpha, combined ...
Tributes are being paid to former Kerrang! editor, music journalist and podcaster James McMahon, who passed away aged 44 on ...
Citation: Clinical trial shows immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma (2024, November 12) retrieved 15 November 2024 from https://medicalxpress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback